Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancerY J Kim, S-A Im, H G Kim, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatmentE An, C-Y Ock, T-Y Kim, et al.British Journal of Cancer|May 9, 2013
Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapyD-W Lee, S-W Han, H J Lee, et al.Cancer Research and Treatment|December 19, 2015
Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung CancerY H Joh, T Y Kim, I I Na, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surfaceH W Sohn, Y K Shin, I S Lee, et al.ESMO Open|February 26, 2026
Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinomaK Shitara, Y-J Bang, L S Wyrwicz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2018
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300Y-J Bang, E Yañez Ruiz, E Van Cutsem, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2016
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized studyS Faivre, P Niccoli, D Castellano, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2019
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumorsM D Hellmann, T-W Kim, C B Lee, et al.The Journal of International Medical Research|August 9, 2002
Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetronY K Kang, Y H Park, B Y Ryoo, et al.Pageof 10